Novo Integrated Sciences Inc. (NVOS) has experienced a decrease of -4.45% in its stock price, despite a 2.34% gain. The company has had a bad performance lately and is currently trading at a significant distance from its 50-day moving average and its 52-week high. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. NVOS has debt to equity ratios of 31.25 and long-term debt to equity ratios of 18.67. The enterprise to sales ratio is 0.98, and the liquidity ratio stands at 1.32.
Novo Integrated Sciences Inc. (NVOS) Shares Decline Despite Market Volatility
Novo Integrated Sciences Inc. (NASDAQ: NVOS) has experienced a decrease of -4.45% in its stock price compared to its previous closing price of $0.12. However, despite this decline, the company has witnessed a 2.34% gain in its stock.
NVOS Market Performance
NVOS stock saw a weekly decrease of 2.34%, with a monthly decline of -7.80% and a quarterly decrease of -46.39%. The volatility ratio for the week is 14.61%, while the volatility levels for the last 30 days are 16.51%. The simple moving average for the last 20 days is -11.98%, with a simple moving average of -85.90% for the last 200 days.
NVOS Trading at -9.97% from the 50-Day Moving Average
NVOS stock has stumbled in the market, settling with a loss of -96.44% for the last 52 weeks. The volatility rate increased by 14.61% over the last 30 days, as shares sank -4.14% for the moving average over the last 20 days. In contrast, over the last 50 days, the stock is trading -32.07% lower at present.
During the last 5 trading sessions, NVOS rose by +2.34%, which changed the moving average for the period of 200-days by -94.06% compared to the 20-day moving average, which settled at $0.1340. Novo Integrated Sciences Inc. saw -41.22% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports indicate several insider trading activities at NVOS, including Oliva Robert Letterio, the Director of Novo Integrated Sciences Inc., who purchased 5,000 shares at $2.23 during a trade that took place on April 19. After this action, Oliva Robert Letterio now owns 217,717 shares of NVOS valued at $11,156 using the latest closing price.
Stock Fundamentals for NVOS
Current profitability levels for the company are sitting at -45.93 for the present operating margin and +23.88 for the gross margin. The net margin for NVOS stands at -47.95. The total capital return value is set at -9.34, while invested capital returns managed to touch -10.51. Equity return is now at value -28.00, with -18.40 for asset returns.
The public float for NVOS is 12.54M, with short sellers holding 7.11% of that float. The average trading volume of NVOS on March 24, 2023 was 28.26M shares.
Novo Integrated Sciences Inc. (NVOS) Capital Structure and Ratios
Novo Integrated Sciences Inc. (NVOS) has a debt to equity ratio of 31.25, a total debt to capital ratio of 23.81, and a total debt to assets ratio of 22.13. The long-term debt to equity ratio is 18.67, and the long-term debt to capital ratio is 14.23.
The company’s enterprise to sales ratio is 0.98, with a debt to enterprise value settled at 0.27. The receivables turnover is 4.31, and the total asset turnover is 0.19. The liquidity ratio stands at 1.32.
NVOS Performance
NVOS has had a bad performance lately, with the stock currently trading at a significant distance from its 50-day moving average and its 52-week high. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”.
Don’t miss interesting posts on Famousbio
